327 related articles for article (PubMed ID: 15313947)
1. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
[TBL] [Abstract][Full Text] [Related]
2. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function.
Cortés B; Núñez I; Cofán M; Gilabert R; Pérez-Heras A; Casals E; Deulofeu R; Ros E
J Am Coll Cardiol; 2006 Oct; 48(8):1666-71. PubMed ID: 17045905
[TBL] [Abstract][Full Text] [Related]
4. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
[TBL] [Abstract][Full Text] [Related]
5. Supplements of L-arginine attenuate the effects of high-fat meal on endothelial function and oxidative stress.
Lin CC; Tsai WC; Chen JY; Li YH; Lin LJ; Chen JH
Int J Cardiol; 2008 Jul; 127(3):337-41. PubMed ID: 17659795
[TBL] [Abstract][Full Text] [Related]
6. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
[TBL] [Abstract][Full Text] [Related]
7. Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease.
Zhao SP; Liu L; Cheng YC; Li YL
Atherosclerosis; 2003 Jun; 168(2):375-80. PubMed ID: 12801622
[TBL] [Abstract][Full Text] [Related]
8. Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China coronary secondary prevention study (CCSPS).
Zhao SP; Lu ZL; Du BM; Chen Z; Wu YF; Yu XH; Zhao YC; Liu L; Ye HJ; Wu ZH;
J Cardiovasc Pharmacol; 2007 Feb; 49(2):81-4. PubMed ID: 17312447
[TBL] [Abstract][Full Text] [Related]
9. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
[TBL] [Abstract][Full Text] [Related]
10. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
Chan YH; Lau KK; Yiu KH; Li SW; Chan HT; Fong DY; Tam S; Lau CP; Tse HF
Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypertriglyceridemia on endothelial dysfunction during statin ± ezetimibe therapy in patients with coronary heart disease.
Yunoki K; Nakamura K; Miyoshi T; Enko K; Kubo M; Murakami M; Hata Y; Kohno K; Morita H; Kusano KF; Ito H
Am J Cardiol; 2011 Aug; 108(3):333-9. PubMed ID: 21545981
[TBL] [Abstract][Full Text] [Related]
13. [Influence of postprandial hypertriglyceridemia on the endothelial function in elderly patients with coronary heart disease].
Liu L; Zhao SP; Gao M
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):259-62. PubMed ID: 12575310
[TBL] [Abstract][Full Text] [Related]
14. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles.
Ferreira AC; Peter AA; Mendez AJ; Jimenez JJ; Mauro LM; Chirinos JA; Ghany R; Virani S; Garcia S; Horstman LL; Purow J; Jy W; Ahn YS; de Marchena E
Circulation; 2004 Dec; 110(23):3599-603. PubMed ID: 15569844
[TBL] [Abstract][Full Text] [Related]
15. Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults.
Volek JS; Judelson DA; Silvestre R; Yamamoto LM; Spiering BA; Hatfield DL; Vingren JL; Quann EE; Anderson JM; Maresh CM; Kraemer WJ
Am J Cardiol; 2008 Nov; 102(10):1413-7. PubMed ID: 18993165
[TBL] [Abstract][Full Text] [Related]
16. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X.
Li JJ; Wang Y; Nie SP; Li Q; Li YS; Huang Y; Hui RT
Int J Cardiol; 2007 Oct; 122(1):82-4. PubMed ID: 17196275
[TBL] [Abstract][Full Text] [Related]
17. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
18. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
[TBL] [Abstract][Full Text] [Related]
19. Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.
Westphal S; Abletshauser C; Luley C
Coron Artery Dis; 2009 Jan; 20(1):81-5. PubMed ID: 19060628
[TBL] [Abstract][Full Text] [Related]
20. Vasoprotective endothelial effects of a standardized grape product in humans.
Chaves AA; Joshi MS; Coyle CM; Brady JE; Dech SJ; Schanbacher BL; Baliga R; Basuray A; Bauer JA
Vascul Pharmacol; 2009; 50(1-2):20-6. PubMed ID: 18805507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
